已收盤 09-19 16:00:00 美东时间
+1.440
+6.84%
RBC Capital analyst Gregory Renza reiterates Viridian Therapeutics (NASDAQ:VRDN) with a Outperform and maintains $44 price target.
09-19 22:11
ANI Pharmaceuticals (ANIP) said it completed its planned acquisition of Alimera Sciences (NASDAQ:ALIM). Under the terms of the merger agreement, ANI acquired all of the outstanding shares of Alimera...
09-16 21:04
Viridian Therapeutics Inc : RBC Raises Target Price to $44 From $35
09-13 13:53
Viridian Therapeutics (NASDAQ:VRDN) shares dropped 2% after-hours on Wednesday after the biotechnology company priced an upsized underwritten public offering of common stock and preferred stock, compr...
09-12 14:12
新药疗效击败默沙东!生物制药公司SMMT再涨20%,近两个交易日累涨87%;宣布启动1亿美元股票回购计划,康丽数码飙升20%>>
09-11 19:14
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives.
09-11 02:09
Rubrik's (NYSE:RBRK) second-quarter results and raised guidance are indicative that the company is making "solid progress on efficient growth," investment firm Baird said. Shares fell 5% in midday tra...
09-11 01:47
Analyst Jason Butler of JMP Securities reiterated a Buy rating on Viridian Ther...
09-11 00:45
Shares of Oracle (NYSE:ORCL) popped over 11% on Tuesday after the computer software firm provided investors with fiscal first quarter results that surpassed estimates. While the Texas headquartered co...
09-10 23:50
JPMorgan Chase (NYSE:JPM) stock slid 6.2% in Tuesday morning trading as Daniel Pinto, the bank's president and chief operating officer, said next year's net interest income "will be lower" than what a...
09-10 23:07